Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free Zones
DOHA, Qatar, Feb. 27, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, has announced today the signing of an agreement with Qatar Free Zones Authority (QFZ) and Doha Venture Capital (DVC) to build the first Center for Unified Biosecurity Excellence in Doha (CUBE-D) within Qatar Free Zones. The signing took place alongside QFZ's and DVC's participation in the Web Summit Qatar, in a ceremony attended by HE. Dr. Ahmad Al-Sayed, Minister of State and Chairman of QFZ/DVC, HE. Mohammed bin Ali Al Mannai, Minister of Communications and Information Technology (MCIT) and Vice Chairman of QFZ/DVC, and Matthew McKnight, General Manager for Biosecurity, Ginkgo Bioworks, along with executives from the ministry and the three signing entities.
- The signing took place alongside QFZ's and DVC's participation in the Web Summit Qatar, in a ceremony attended by HE.
- CUBE-D's advanced platform is expected to serve as a nucleus for global pathogen monitoring efforts and be a key hub in Ginkgo's bioradar network.
- I am proud of Ginkgo's ability to technically and socially synthesize this global immune system, one node and hub at a time.
- Matthew McKnight, General Manager of Biosecurity at Ginkgo Bioworks: "CUBE-D represents the next generation of biosecurity infrastructure.